S Claiborne Johnston, MD, PhD

Dean, Vice President for Medical Affairs

1988 …2019
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Bio

Since March 2014, Clay Johnston has served as the inaugural Dean of the Dell Medical School at The University of Texas at Austin. His ambitious vision includes building a world-class medical school by creating a vital, inclusive health ecosystem that supports new and innovative models of education and healthcare delivery- all with a focus on improving health and making Austin a model healthy city. He is also a neurologist, specializing in stroke care and research.

Previously, Clay was associate vice chancellor for research at the University of California, San Francisco. He also directed the Clinical and Translational Science Institute, overseeing the planning, development, and implementation of a $112-million, five-year, National Institutes of Health (NIH) grant award; and founded the UCSF Center for Healthcare Value to engage faculty and trainees in improving the quality of care while also lowering costs.

He is a graduate of Amherst College, and Harvard Medical School. He later received a PhD in epidemiology from the University of California, Berkeley, and was a resident in Neurology at UCSF, where he later trained in Vascular Neurology. During his 20 years at UCSF, he rose the academic ranks to Professor of Neurology and Epidemiology, and directed the Stroke Service.

Clay has authored more than 300 publications in scientific journals and has won several national awards for his research and teaching. In particular, he has published extensively in the prevention and treatment of stroke and transient ischemic attack. He is perhaps best known for his studies describing the short-term risk of stroke in patients with transient ischemic attack and identifying patients at greatest risk, and also for his work related to measuring the impact of research. He has led several large cohort studies of cerebrovascular disease and three international multicenter randomized trials, two of which are ongoing.

Fingerprint Dive into the research topics where S Claiborne Johnston is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles
Stroke Medicine & Life Sciences
Transient Ischemic Attack Medicine & Life Sciences
clopidogrel Medicine & Life Sciences
Intracranial Aneurysm Medicine & Life Sciences
Aspirin Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Subarachnoid Hemorrhage Medicine & Life Sciences
Neurology Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1988 2019

2 Citations (Scopus)

Academic Medical Centers: Too Large for Their Own Health?

Johnston, S. C., Jul 16 2019, In : JAMA - Journal of the American Medical Association. 322, 3, p. 203-204 2 p.

Research output: Contribution to journalShort survey

Health
2 Citations (Scopus)

Acute dual antiplatelet therapy for minor ischaemic stroke or transient ischaemic attack

Wang, Y., Johnston, S. C., Bath, P. M., Grotta, J. C., Pan, Y., Amarenco, P., Wang, Y., Simon, T., Kim, J. S., Jeng, J. S., Liu, L., Lin, Y., Wong, K. S. L., Wang, D. & Li, H., Jan 1 2019, In : BMJ (Online). 364, l895.

Research output: Contribution to journalArticle

Open Access
Transient Ischemic Attack
Stroke
Therapeutics
2 Citations (Scopus)

Association between ABCB1 Polymorphisms and Outcomes of Clopidogrel Treatment in Patients with Minor Stroke or Transient Ischemic Attack: Secondary Analysis of a Randomized Clinical Trial

Pan, Y., Chen, W., Wang, Y., Li, H., Johnston, S. C., Simon, T., Zhao, X., Liu, L., Wang, D., Meng, X. & Wang, Y., May 2019, In : JAMA Neurology. 76, 5, p. 552-560 9 p.

Research output: Contribution to journalArticle

clopidogrel
Transient Ischemic Attack
Randomized Controlled Trials
Stroke
Aspirin
Aspirin
Stroke
Research Personnel
Therapeutics
Confidence Intervals

Influence of smoking on CYP2C19 genetic variants and clopidogrel efficacy in patients with minor stroke or transient ischaemic attack

on behalf of the CHANCE investigators, Jan 1 2019, In : European Journal of Neurology. 26, 9, p. 1175-1182 8 p.

Research output: Contribution to journalArticle

clopidogrel
Transient Ischemic Attack
Smoking
Stroke
Aspirin